Showing 5721-5730 of 5956 results for "".
- Eyepatch With Dissolvable Needles Used to Treat Eye Diseasehttps://modernod.com/news/eyepatch-with-dissolvable-needles-used-to-treat-eye-disease/2479667/A team of researchers affiliated with several institutions in Singapore has developed an eyepatch with dissolvable needles for use in treating eye diseases, according to a report in Medical Xpress.
- New Melanoma Treatments Do Not Supplant Surgery as First-Line Therapyhttps://modernod.com/news/new-melanoma-treatments-do-not-supplant-surgery-as-first-line-therapy/2479670/Although several new melanoma treatments have shown promise, none replaces surgery as the primary therapy yet, according to updated guidelines from the American Academy of Dermatology (AAD), as reported in Reuters Health. “Su
- Eyegate Pharma Announces Positive Results in Second PRK Studyhttps://modernod.com/news/eyegate-pharma-announces-positive-results-in-second-prk-study/2479671/EyeGate Pharmaceuticals announced topline data from its study evaluating the potential of EyeGate’s Ocular Bandage Gel (OBG) to help clinicians better manage corneal epithelial defects in patients following photorefractive keratectomy (PRK) surgery, compared to current standard of care. “T
- Ophthotech Announces Results from Phase 2a Safety Trial of Zimura in Combination with Lucentis in Wet AMDhttps://modernod.com/news/ophthotech-announces-results-from-phase-2a-safety-trial-of-zimura-in-combination-with-lucentis-in-wet-amd/2479673/Ophthotech announced the results from its phase 2a safety trial of Zimura (avacincaptad pegol), the company’s complement factor C5 inhibitor, in patients with wet age-related macular degeneration (AMD). This trial was designed to evaluate the safety of different dosage regimens of Zimura combinat
- Acucela Initiates Phase 3 Study of Emixustat Addressing Patients with Stargardt Diseasehttps://modernod.com/news/acucela-initiates-phase-3-study-of-emixustat-addressing-patients-with-stargardt-disease/2479674/Acucela announced that on November 7, 2018, the first patient has enrolled in a study to evaluate Acucela’s leading drug candidate, emixustat hydrochloride (emixustat), in subjects with macular atrophy secondary to Stargardt disease. The study is a multicenter, randomized, double-masked, a
- Small-Particle Air Pollution May Raise Glaucoma Risk in Somehttps://modernod.com/news/small-particle-air-pollution-may-raise-glaucoma-risk-in-some/2479675/In people who already have a genetic vulnerability, small-particle air pollution known as black carbon may raise the risk of developing glaucoma, a new study suggests, according to a Reuters report. Researchers found that in older
- Calcified Nodules Linked to AMD Progressionhttps://modernod.com/news/calcified-nodules-linked-to-amd-progression/2479682/The presence of a specific type of calcified nodule in the retinal drusen of patients with age-related macular degeneration (AMD) is associated with a more than sixfold increased risk for late-stage progression of the disease, a study has shown, according to a Medscape
- Opternative Secures $9M in Most Recent Round of Fundinghttps://modernod.com/news/opternative-secures-9m-in-most-recent-round-of-funding/2479683/Opternative announced it has secured $9 million in its latest round of funding. The round of financing was led by Trust Ventures and Pritzker Group Venture Capital, with an additional investment from existing investor Jump Capital. Opternative will use the fun
- Eye Health America Completes Acquisition of Tampa Bay-Based Updegraff Laser Visionhttps://modernod.com/news/eye-health-america-completes-acquisition-of-tampa-bay-based-updegraff-laser-vision/2479695/Eye Health America (EHA) announced its sixth acquisition of the year, adding Updegraff Laser Vision to its roster of prominent eye care member practices in the Southeast United States. Terms of the deal were not disclosed. The acquisition of the Tampa Bay-based practice continues to
- OCT Screening Before Cataract Surgery Can Improve Outcomeshttps://modernod.com/news/oct-screening-before-cataract-surgery-can-improve-outcomes/2479699/The routine use of optical coherence tomography (OCT) to screen candidates for cataract surgery can improve surgery timing and planning, give patients realistic expectations, and even lead to changes in treatment plans, results from a new study show, according to a Medscape